PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
27611715-4	2016	Our results showed that in the patient"s group the percentage of CD4(+)IL-4(+) cells was significantly increased in the presence of all concentrations of NaB when PBMCs were stimulated by MBP (p = 0.001) or PHA (p < 0.03).	nab	154-157	CD4 molecule	Homo sapiens	65-68	
27941965-9	2016	In HIV-infected participants, each 10% increase in CD4/CD8 ratio predicted a mean 21% higher post-baseline YFV Nab titer (p = 0.024).	nab	111-114	CD4 molecule	Homo sapiens	51-54	
29162799-4	2017	We here employ computational and structure-guided design to develop improved native-like trimers that reduce exposure of non-nAb epitopes in the V3-loop and trimer base, minimize both CD4 reactivity and CD4-induced non-nAb epitope exposure, and increase thermal stability while maintaining bnAb antigenicity.	nab	125-128	CD4 molecule	Homo sapiens	184-187	
29162799-4	2017	We here employ computational and structure-guided design to develop improved native-like trimers that reduce exposure of non-nAb epitopes in the V3-loop and trimer base, minimize both CD4 reactivity and CD4-induced non-nAb epitope exposure, and increase thermal stability while maintaining bnAb antigenicity.	nab	125-128	CD4 molecule	Homo sapiens	203-206	
29162799-4	2017	We here employ computational and structure-guided design to develop improved native-like trimers that reduce exposure of non-nAb epitopes in the V3-loop and trimer base, minimize both CD4 reactivity and CD4-induced non-nAb epitope exposure, and increase thermal stability while maintaining bnAb antigenicity.	nab	219-222	CD4 molecule	Homo sapiens	203-206	
28539451-8	2017	The additional introduction of the E64K ground-state stabilizing substitution markedly reduced or ablated soluble CD4 (sCD4) induction of non-NAb epitopes in V3 and/or associated with the coreceptor binding site.	nab	142-145	CD4 molecule	Homo sapiens	114-117	
28279830-2	2017	In new immunizations, we attempted to improve nAb responses by removing the N362 glycan that also lines the CD4bs.	nab	46-49	CD4 molecule	Homo sapiens	108-111	
27611715-6	2016	Moreover, in the patient"s group the percentage of CD4(+)IFN-gamma(+) cells was decreased significantly when the PBMCs were stimulated by PHA and NaB (p < 0.004) or by MBP and 1000 microg/ml of NaB (p < 0.03).	nab	146-149	CD4 molecule	Homo sapiens	51-54	
27611715-6	2016	Moreover, in the patient"s group the percentage of CD4(+)IFN-gamma(+) cells was decreased significantly when the PBMCs were stimulated by PHA and NaB (p < 0.004) or by MBP and 1000 microg/ml of NaB (p < 0.03).	nab	197-200	CD4 molecule	Homo sapiens	51-54	
19567243-5	2009	The NAb specificities for SOSIP antisera mapped in part to the CD4 binding site on gp120.	nab	4-7	CD4 molecule	Homo sapiens	63-66	
20860805-9	2010	Interestingly, we found that the sensitivity of Envs to contemporaneous autologous NAbs correlated positively with increased sensitivity to soluble CD4 and inversely with anti-CD4 antibody and Envs with increased NAb sensitivity were able to efficiently infect HeLa cells expressing low CD4.	nab	83-86	CD4 molecule	Homo sapiens	148-151	
20860805-9	2010	Interestingly, we found that the sensitivity of Envs to contemporaneous autologous NAbs correlated positively with increased sensitivity to soluble CD4 and inversely with anti-CD4 antibody and Envs with increased NAb sensitivity were able to efficiently infect HeLa cells expressing low CD4.	nab	83-86	CD4 molecule	Homo sapiens	176-179	
20860805-9	2010	Interestingly, we found that the sensitivity of Envs to contemporaneous autologous NAbs correlated positively with increased sensitivity to soluble CD4 and inversely with anti-CD4 antibody and Envs with increased NAb sensitivity were able to efficiently infect HeLa cells expressing low CD4.	nab	83-86	CD4 molecule	Homo sapiens	176-179